logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9714257 B1

PDFFull Text
Date of Patent:
Jul. 25, 2017

Filed:

Apr. 21, 2015

Therapeutic agent for motor disorders

Applicant:

Kyowa Hakko Kirin Co., Ltd., Chiyoda-ku, Tokyo, JP;

Inventors:

Noriaki Uesaka, Shizuoka, JP;

Takashi Sawada, Shizuoka, JP;

Tomoyuki Kanda, Shizuoka, JP;

Assignee:

KYOWA HAKKO KIRIN CO., LTD., Tokyo, JP;

Attorney:

Fitzpatrick Cella Harper and Scinto

Primary Examiner:

Jeffrey S Lundgren

Assistant Examiner:

Michael Schmitt

Int. Cl.
CPC ...
A61K 31/4439 (2006.01); A61K 31/506 (2006.01); A61K 31/427 (2006.01); A61K 31/4709 (2006.01); A61K 31/4355 (2006.01); A61K 31/435 (2006.01); A61K 31/4365 (2006.01); A61K 31/198 (2006.01); C07D 495/04 (2006.01); A61K 31/436 (2006.01); A61K 31/5377 (2006.01); C07D 417/14 (2006.01); C07D 491/048 (2006.01); C07D 491/052 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01); A61K 31/198 (2013.01); A61K 31/427 (2013.01); A61K 31/435 (2013.01); A61K 31/436 (2013.01); A61K 31/4355 (2013.01); A61K 31/4365 (2013.01); A61K 31/4439 (2013.01); A61K 31/4709 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); C07D 417/14 (2013.01); C07D 491/048 (2013.01); C07D 491/052 (2013.01);
Abstract

Provided are an agent for the treatment and/or prophylaxis of a movement disorder, the agent for the treatment and/or prophylaxis wherein the movement disorder is extrapyramidal syndrome, the agent for the treatment and/or prophylaxis wherein the movement disorder is bradykinesia, gait disturbance, dystonia, dyskinesia or tardive dyskinesia, the agent for the treatment and/or prophylaxis wherein the movement disorder is a side effect of L-DOPA and/or dopamine agonist therapy, and the like, each containing a thiazole derivative represented by the formula (I) wherein Rrepresents aryl and the like, and Rrepresents pyridyl or the like, or a pharmaceutically acceptable salt thereof as an active ingredient.

Find Patent Forward Citations

Loading…